目录
- Celiac Disease in Asia beyond the Middle East and Indian subcontinent: Epidemiological burden and diagnostic barriers
- Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease
- Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?
- Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease
- Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: A literature review
- Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics
- Burden of venous thromboembolism in patients with pancreatic cancer
- Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19
- Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease
- Changes in the nutritional status of nine vitamins in patients with esophageal cancer during chemotherapy
- Effects of sepsis and its treatment measures on intestinal flora structure in critical care patients
- Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study
- Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials